豪享彩票

+86 400-821-9890

Publications

豪享彩票 Explore a selection of 100+ publications since our founding

  • 2019/03 AACR

    Correlation analysis between PD-L1 expression, TMB and clinical characteristics in Chinese non-small cell lung cancer
    Comprehensive genomic profiling in Chinese patients with pulmonary sarcomatoid carcinoma
    HER2 amplification and microsatellite status distribution in Chinese gastric cancer patients
    The landscape of germline mutations in Chinese patients with solid tumors
    Genomic alterations of BRCA1/2 genes in Chinese solid tumor patients
    Comparison of mutations in different subtypes of sarcomas and its clinical implications
    The landscape of FGFR variations in Chinese solid tumor patients
    The impact of genomic mutational status on PD-L1 expression and tumor mutation burden in non-small cell lung cancer
    The impact of PIK3CA/PTEN/AKT1 genes in advanced NSCLC patients with acquired EGFR-TKI resistance and clinical response to EGFR-TKI
    Genomic profiling of non-small cell lung cancer in Xuanwei, Yunnan Province in China
    Genomic alteration, tumor mutation burden and PD-L1 status of Chinese hepatic angiosarcoma patients
    Alterations of DNA damage repair genes in Chinese primary liver cancer patients and its association with tumor mutation burden
    Landscape of genomic alterations across solid tumors based on a comprehensive clinical sequencing analysis of 5355 Chinese cancer
  • 2018/10 Hepatobiliary Pancreat Dis Int 2018

    Trastuzumab, not lapatinib, has therapeutic effects on Chinese patients with HER2-positive cholangiocarcinoma
  • 2018/10 ESMO 2018

    Assocation of MMR protein expression and MMR gene mutations in China colorectal cancer patients
    Somatic and germline mutaions of Chinese gastic cancer patients
    The landscape of NTRK fusions in Chinese solid tumor patients
    Effects of concomitant genetic alterations on cancer patient overall survival
    EML4-ALK fusion variants associate with gender and age in Chinese NSCLC patients
  • 2018/09 WCLC 2018

    Co-occurring genomic alterations in EGFR altered Chinese lung adenocarcinoma patients
    Genomic profiling of Chinese small cell lung cancer and the implications for therapy
    Apatinib plus Icotinib as first-line therapy for EGFR co-mutations NSCLC in Chinese patients: an exploratory study
  • 2018/08 Cancer Commun(Lond)2018

    Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma
  • 2018/07 J Thorac Oncol 2018(case report)

    Next-Generation Sequencing Assisted in Establishing the Diagnosis and Treatment for a Chinese Patient With Breast and Lung Multiple Primary Malignancies
  • 2018/06 ASCO 2018

    Association analysis of the combination of tumor burden and PD-L1 expression and response to PD-1 L1 inhibitors in Chinese cancer patients
    Characterization of genomic alterations, tumor mutational burden and PDL1 expression in 181 Chinese hepatocellular carcinomas
    Correlation of tumor mutational burden and predicted functional impact of mutations across cancer types
    Comprehensive circulating tumor DNA profiling of driver genes in Chinese NSCLC patients
    Circulating tumor DNA analysis for osimertinib resistance Chinese NSCLC patients
    The utility of integrative genomic profiling in Sarcoma diagnosis and treatment
    Comprehensive analysis of genomic alterations in Chinese high-grade serous ovarian carcinoma patients
    Comprehensive genomic profiling in Chinese patients with clear cell renal cell carcinoma
    Genomic profiling of Chinese pancreatic adenocarcinoma and the implications for therapy
    Pan-cancer genomic features of PIK3CA/PTEN and clinical response to everolimus in Chinese population
    Pan-cancer genomic variation characteristics of CDKN2A/CDKN2B/CCND1 in Chinese patients
    Genomic feature differences in APC-mutant and wild-type colorectal cancer patients
    Genomic diversity between Asian and United States intrahepatic cholangiocarcinoma patients
  • 2018/04 Lung Cancer 2018(case report)

    dentification of a novel KIF13A-RET fusion in lung adenocarcinoma by next-generation sequencing
  • 2018/04 AACR 2018

    Analysis of association between homologous recombination deficiency and tumor mutational burden in solid tumors
    G1/S transition-related gene mutations associate with survival of hepatocellular carcinoma patients
    Higher level of tumor mutational burden and 11q13 amplification in Chinese hepatocellular carcinoma patients
    Associations of genomic alteration, tumor mutational burden with PD-L1 expression and response to immune checkpoint inhibitors in Chinese lung patients
    Comparison of gene copy number variations(CNV)in primary and metastatic lung cancers
    High incidence of POLE mutations in Chinese colorectal cancer patients identified by comprehensive genomic profiling
    The difference of molecular signatures in Chinese left-and right-sided colorectal cancer patients
    High incidence of ERBB2 amplification associated with microsatellite stable status in Chinese colorectal cancer patients
  • 2018/03 Nat Cell Biol 2018

    The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168
  • 2018/03 USCAP 2018

    Development and validation of a microsatellite instability status calling method based on next generation DNA sequencing
  • 2018/02 JCO Precis Oncol 2018

    Genomic Profiling of T-Cell Neoplasms Reveals Frequent JAK1 and JAK3 Mutations With Clonal Evasion From Targeted Therapie
  • 2018/01 ASCO-GI 2018

    The pathway regulating RhoA activity to predict the survival of gastric cancers
    Lenvatinib plus PD-1 inhibitors in patients with advanced intrahepatic cholangiocarcinoma: Preliminary data and correlation with next-generation sequencing
  • 2017/10 MAP 2017

    The landscape of kinase fusions in 445 Chinese NSCLC patients( Annals of Oncology )
    A model based adjustment for tumor mutational burden across different tumor types(Annals of Oncology)
  • 2017/10 WCLC 2017

    mTOR pathway altertions may mediate PD-1/PD-L1 blockade resistance in non-small cell lung cancer
    Genomic profiling of driver gene mutations in 498 Chinese NSCLC patients
    The potential clinical application of comprehensive genomic profiling in targeted therapy and immunotherapy of lung cancer
  • 2017/09 EMSO 2017

    Analytical and clinical validation of a next-generation sequencing-based circulating tumor DNA(ctDNA)assay assures its clinical application (Annals of Oncology)
  • 2017/08 LUNG CANCER 2017

    Identification of a Novel KIF13A-RET Fusion in Lung Adenocarcinoma by Next-generation Sequencing
  • 2017/06 J Gastrointest Oncol 2017

    Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies
  • 2017/06 World J Gastroenterol 2017(case report)

    Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation
  • 2017/06 ASCO 2017

    A novel approach to detect large indels from targeted sequencing data in clinical cancer setting
  • 2017/06 CANCER 2017

    Comprehensive Genomic Profiling of Different Subtypes of Nasopharyngeal Carcinoma Reveals Similarities and Differences to Guide Targeted Therapy Cancer
豪享彩票_安全购彩 豪享彩票_官网 豪享彩票|官方指定! 豪享彩票-豪享彩票 豪享彩票-豪享彩票